Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Shima

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
The American Journal of Pathology|February 19, 2013
VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucomaRichard H Foxton, Arthur Finkelstein, Sauparnika Vijay, et al.
The Journal of Experimental Medicine|October 1, 2008
Delta-like 4 is indispensable in thymic environment specific for T cell developmentKatsuto Hozumi, Carolina Mailhos, Naoko Negishi, et al.
Diabetologia|August 11, 2018
BTBR ob/ob mouse model of type 2 diabetes exhibits early loss of retinal function and retinal inflammation followed by late vascular changesVivian K Lee, Brett M Hosking, Joanna Holeniewska, et al.
Investigative Ophthalmology & Visual Science|February 1, 2008
Simultaneous but not prior inhibition of VEGF165 enhances the efficacy of photodynamic therapy in multiple models of ocular neovascularizationMeihua Ju, Carolina Mailhos, John Bradley, et al.
Genes & Development|November 17, 2004
Vascular endothelial growth factor controls neuronal migration and cooperates with Sema3A to pattern distinct compartments of the facial nerveQuenten Schwarz, Chenghua Gu, Hajime Fujisawa, et al.
The American Journal of Pathology|June 27, 2007
Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injuryKazuaki Nishijima, Yin-Shan Ng, Lichun Zhong, et al.
Investigative Ophthalmology & Visual Science|January 28, 2004
VEGF164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2Tomohiko Usui, Susumu Ishida, Kenji Yamashiro, et al.
Investigative Ophthalmology & Visual Science|May 22, 2014
Spontaneous CNV in a novel mutant mouse is associated with early VEGF-A-driven angiogenesis and late-stage focal edema, neural cell loss, and dysfunctionNorihiro Nagai, Pete Lundh von Leithner, Kanako Izumi-Nagai, et al.
The American Journal of Pathology|July 19, 2015
Novel CCR3 Antagonists Are Effective Mono- and Combination Inhibitors of Choroidal Neovascular Growth and Vascular PermeabilityNori Nagai, Meihua Ju, Kanako Izumi-Nagai, et al.
Investigative Ophthalmology & Visual Science|February 7, 2013
Assessing a novel depot delivery strategy for noninvasive administration of VEGF/PDGF RTK inhibitors for ocular neovascular diseaseScott J Robbie, Peter Lundh von Leithner, Meihua Ju, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
The American Journal of Pathology|February 19, 2013
VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucomaRichard H Foxton, Arthur Finkelstein, Sauparnika Vijay, et al.
The Journal of Experimental Medicine|October 1, 2008
Delta-like 4 is indispensable in thymic environment specific for T cell developmentKatsuto Hozumi, Carolina Mailhos, Naoko Negishi, et al.
Diabetologia|August 11, 2018
BTBR ob/ob mouse model of type 2 diabetes exhibits early loss of retinal function and retinal inflammation followed by late vascular changesVivian K Lee, Brett M Hosking, Joanna Holeniewska, et al.
Investigative Ophthalmology & Visual Science|February 1, 2008
Simultaneous but not prior inhibition of VEGF165 enhances the efficacy of photodynamic therapy in multiple models of ocular neovascularizationMeihua Ju, Carolina Mailhos, John Bradley, et al.
Genes & Development|November 17, 2004
Vascular endothelial growth factor controls neuronal migration and cooperates with Sema3A to pattern distinct compartments of the facial nerveQuenten Schwarz, Chenghua Gu, Hajime Fujisawa, et al.
The American Journal of Pathology|June 27, 2007
Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injuryKazuaki Nishijima, Yin-Shan Ng, Lichun Zhong, et al.
Investigative Ophthalmology & Visual Science|January 28, 2004
VEGF164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2Tomohiko Usui, Susumu Ishida, Kenji Yamashiro, et al.
Investigative Ophthalmology & Visual Science|May 22, 2014
Spontaneous CNV in a novel mutant mouse is associated with early VEGF-A-driven angiogenesis and late-stage focal edema, neural cell loss, and dysfunctionNorihiro Nagai, Pete Lundh von Leithner, Kanako Izumi-Nagai, et al.
The American Journal of Pathology|July 19, 2015
Novel CCR3 Antagonists Are Effective Mono- and Combination Inhibitors of Choroidal Neovascular Growth and Vascular PermeabilityNori Nagai, Meihua Ju, Kanako Izumi-Nagai, et al.
Investigative Ophthalmology & Visual Science|February 7, 2013
Assessing a novel depot delivery strategy for noninvasive administration of VEGF/PDGF RTK inhibitors for ocular neovascular diseaseScott J Robbie, Peter Lundh von Leithner, Meihua Ju, et al.
Pageof 5